- Home
- RPD vs TXG Comparison
RPD vs TXG Comparison
Compare RPD & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPD
- TXG
- Stock Information
- Founded
- RPD 2000
- TXG 2012
- Country
- RPD United States
- TXG United States
- Employees
- RPD N/A
- TXG 1306
- Industry
- RPD Computer Software: Prepackaged Software
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- RPD Technology
- TXG Industrials
- Exchange
- RPD Nasdaq
- TXG Nasdaq
- Market Cap
- RPD 1.5B
- TXG 1.3B
- IPO Year
- RPD 2015
- TXG 2019
- Fundamental
- Price
- RPD $23.39
- TXG $10.81
- Analyst Decision
- RPD Hold
- TXG Buy
- Analyst Count
- RPD 19
- TXG 15
- Target Price
- RPD $32.94
- TXG $15.81
- AVG Volume (30 Days)
- RPD 680.0K
- TXG 3.7M
- Earning Date
- RPD 08-05-2025
- TXG 08-07-2025
- Dividend Yield
- RPD N/A
- TXG N/A
- EPS Growth
- RPD N/A
- TXG N/A
- EPS
- RPD 0.41
- TXG N/A
- Revenue
- RPD $849,159,000.00
- TXG $624,662,000.00
- Revenue This Year
- RPD $2.81
- TXG N/A
- Revenue Next Year
- RPD $4.05
- TXG $5.70
- P/E Ratio
- RPD $57.29
- TXG N/A
- Revenue Growth
- RPD 6.19
- TXG N/A
- 52 Week Low
- RPD $21.61
- TXG $6.78
- 52 Week High
- RPD $44.48
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- RPD 47.00
- TXG 62.32
- Support Level
- RPD $23.07
- TXG $10.38
- Resistance Level
- RPD $24.17
- TXG $11.10
- Average True Range (ATR)
- RPD 0.74
- TXG 0.57
- MACD
- RPD 0.04
- TXG 0.10
- Stochastic Oscillator
- RPD 35.44
- TXG 83.45
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).